Osteogenesis of Human iPSC-Derived MSCs by PLLA/SF Nanofiber Scaffolds Loaded with Extracellular Matrix
Journal of Tissue Engineering and Regenerative Medicine · 2023
DOI: 10.1155/2023/5280613 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Tissue Engineering and Regenerative Medicine, 2023. Verfasst von Junming Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological Science and Medical Engineering, Donghua University, Shanghai, China. Hauptthemen laut MEDLINE: Nanofibers, Polyesters, Osteogenesis, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shanghai, Chongqing Key Laboratory of Traditional Chinese Medicine, Shanghai Jiao Tong University.
Abstract (Originalsprache)
Bone defects that arise from trauma, skeletal diseases, or tumor resections have become the commonest and most thorny problems in orthopedic clinics. Recently, biocomposite materials used as artificial bone repair materials have provided a promising approach for bone regeneration. In this study, poly (l-lactide acid) (PLLA) and silk fibroin (SF) were used to fabricate nanofiber scaffolds by electrospinning technology. In order to simulate a biomimetic osteoblast microenvironment, decellularized extracellular matrix from osteoblasts was loaded into the biocomposite scaffolds (O-ECM/PLLA/SF). It was found that the O-ECM/PLLA/SF scaffolds were nontoxic for L929 cells and had good cytocompatibility. Their effects on mesenchymal stem cells derived from human-induced pluripotent stem cell (iPSC-MSC) behavior were investigated. As a result, the scaffolds with the addition of O-ECM showed enhanced alizarin red S (ARS) activity. In addition, higher expression of osteogenic gene markers such as runt-related transcription factor 2 (Runx2), collagen type I (Col-1), and osteocalcin (OCN) as well as upregulated expression of osteogenic marker protein osteopontin (OPN) and Col-1 further substantiated the applicability of O-ECM/PLLA/SF scaffolds for osteogenesis. Furthermore, the in vivo study also indicated maximal new bone formation in the skull defect model of Sprague Dawley (SD) rats treated with the O-ECM/PLLA/SF carried by human iPSC-MSCs. Hence, this study suggests that O-ECM/PLLA/SF scaffolds have a potential application in bone tissue engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Biological Science and Medical Engineering, Donghua University, Shanghai, China.
- Department of Orthopedics, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
ORCID-Profile: Xiangxin Lou
Förderung
- Natural Science Foundation of Shanghai
- Chongqing Key Laboratory of Traditional Chinese Medicine
- Shanghai Jiao Tong University
Zitieren
APA
Zhang, J., Che, L., Wu, Y., Zhou, L., Liu, L., Yue, Y., Song, D., & Lou, X. (2023). Osteogenesis of Human iPSC-Derived MSCs by PLLA/SF Nanofiber Scaffolds Loaded with Extracellular Matrix. Journal of Tissue Engineering and Regenerative Medicine. https://doi.org/10.1155/2023/5280613
Vancouver
Zhang J, Che L, Wu Y, Zhou L, Liu L, Yue Y, et al. Osteogenesis of Human iPSC-Derived MSCs by PLLA/SF Nanofiber Scaffolds Loaded with Extracellular Matrix. Journal of Tissue Engineering and Regenerative Medicine. 2023. doi:10.1155/2023/5280613
BibTeX
@article{Zhang2023,
author = {Zhang, Junming and Che, Lingbin and Wu, Yunliang and Zhou, Lei and Liu, Li and Yue, Yuanhang and Song, Dianwen and Lou, Xiangxin},
title = {Osteogenesis of Human iPSC-Derived MSCs by PLLA/SF Nanofiber Scaffolds Loaded with Extracellular Matrix},
journal = {Journal of Tissue Engineering and Regenerative Medicine},
year = {2023},
doi = {10.1155/2023/5280613}
}
EUVIMED